Literature DB >> 6401669

Effect of inhibitors of prostaglandin synthesis on induced diuresis in cirrhosis.

D Mirouze, R D Zipser, T B Reynolds.   

Abstract

The effect of inhibitors of prostaglandin synthesis on diuretic action was examined in patients with ascites due to chronic liver disease and in normal subjects. In patients with ascites, natriuresis after 80 mg i.v. furosemide was reduced 82% by pretreatment with indomethacin. Creatinine clearance was reduced only 16%. These effects were likely due to inhibition of renal prostaglandin synthesis, since urinary prostaglandin E2 fell and there was also reduction in natriuresis with naproxen (52%). The effects were not specific for furosemide since spironolactone-induced natriuresis was also reduced by indomethacin (82%), naproxen (52%), and aspirin (33%). In normal subjects, indomethacin reduced furosemide natriuresis by only 14% while creatinine clearance was not affected. The mechanisms of these drug interactions are uncertain but probably involve renal hemodynamics which appear to be supported importantly by renal prostaglandins in patients with ascites due to liver disease.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6401669     DOI: 10.1002/hep.1840030108

Source DB:  PubMed          Journal:  Hepatology        ISSN: 0270-9139            Impact factor:   17.425


  16 in total

1.  Effect of albumin-furosemide mixtures on response to furosemide in cirrhotic patients with ascites.

Authors:  D C Brater; N Chalasani; J C Gorski; J C Horlander; R Craven; H Hoen; J Maya
Journal:  Trans Am Clin Climatol Assoc       Date:  2001

Review 2.  The endocrinology and pathophysiology of alcoholic cirrhosis and functional renal failure--a review.

Authors:  E S Domurat; A N Elias
Journal:  J Natl Med Assoc       Date:  1992-02       Impact factor: 1.798

3.  Guidelines on the management of ascites in cirrhosis.

Authors:  K P Moore; G P Aithal
Journal:  Gut       Date:  2006-10       Impact factor: 23.059

4.  Treatment of ascites in patients with cirrhosis of the liver.

Authors:  V Arroyo; P Ginés; J Rodés
Journal:  Intensive Care Med       Date:  1987       Impact factor: 17.440

5.  Ascites.

Authors:  Nelson Garcia; Arun J. Sanyal
Journal:  Curr Treat Options Gastroenterol       Date:  2001-12

Review 6.  Prostaglandins, thromboxanes and leukotrienes in clinical medicine.

Authors:  R D Zipser; G Laffi
Journal:  West J Med       Date:  1985-10

7.  Cyclooxygenase-1 derived prostaglandins are involved in the maintenance of renal function in rats with cirrhosis and ascites.

Authors:  Marta López-Parra; Joan Clària; Anna Planagumà; Esther Titos; Jaime L Masferrer; B Mark Woerner; Alane T Koki; Wladimiro Jiménez; Rosario Altuna; Vicente Arroyo; Francisca Rivera; Joan Rodés
Journal:  Br J Pharmacol       Date:  2002-02       Impact factor: 8.739

8.  Increased urinary excretion of aquaporin 2 in patients with liver cirrhosis.

Authors:  P Ivarsen; J Frøkiaer; N K Aagaard; E F Hansen; F Bendtsen; S Nielsen; H Vilstrup
Journal:  Gut       Date:  2003-08       Impact factor: 23.059

9.  Use of over-the-counter analgesics is not associated with acute decompensation in patients with cirrhosis.

Authors:  Sakib K Khalid; Jill Lane; Victor Navarro; Guadalupe Garcia-Tsao
Journal:  Clin Gastroenterol Hepatol       Date:  2009-04-24       Impact factor: 11.382

Review 10.  Pharmacotherapy of ascites associated with cirrhosis.

Authors:  P Ginès; V Arrovo; J Rodés
Journal:  Drugs       Date:  1992-03       Impact factor: 9.546

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.